XERIS PHARMACEUTICALS, INC. (IL)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2020
- $0
- under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 0
- with positive net obligations4 IDV vehicles held
- Latest action
- Mar 23, 2026
- SAM.gov registration
- Active
- Registration expiration date Dec 18, 2026
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Oct 24, 2005 (21 years)
- Location
- Chicago, IL
- State of incorporation
- Delaware
- Website
- xerispharma.com
† FY2026 obligations (provisional; DoD awards signed after Jul 30, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI YAV5AK7VKJ31. GovChime does not check exclusions.
Performance
Capabilities
NAICS codes
- 325412Pharmaceutical Preparation Manufacturing(primary)Small
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Business types self-reported in SAM.gov registration:
- Self Certified Small Disadvantaged Business
Contracts
Latest awards and orders
- 36E79722A0022Blanket purchase agreement (BPA)VehicleDepartment of Veterans AffairsLatest action
- 36F79720D0153Federal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
- 36F79726D0087Federal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
- 36F79720D009EFederal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for XERIS PHARMACEUTICALS, INC. lists a physical address and a separate mailing address, along with 5 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Mailing Address
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Government Business Contact
CHRISTINE AUGUST
SENIOR MANAGER, MARKET ACCESS
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Electronic Business Contact
ERIC LEWIS
VICE PRESIDENT, MARKET ACCESS
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Past Performance Contact
ERIC LEWIS
VICE PRESIDENT, MARKET ACCESS
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Government Business Alternate Contact
CHRISTINE AUGUST
SENIOR MANAGER, MARKET ACCESS
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Electronic Business Alternate Contact
ERIC LEWIS
VICE PRESIDENT, MARKET ACCESS
1375 W FULTON ST STE 1300
CHICAGO, IL, 60607
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
XERIS PHARMACEUTICALS, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires December 18, 2026.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Registered for disaster relief contracting — Nationwide
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in Illinois with primary NAICS 325412
- Baxter Healthcare CorporationDeerfield, IL
- Medi-Physics, Inc.Arlington Heights, IL
- GE Healthcare IncArlington Heights, IL
- Sagent Pharmaceuticals, IncSchaumburg, IL
- A-S Medication Solutions LLCLibertyville, IL
- Altathera Pharmaceuticals LLCChicago, IL